ATI RN Maternal Newborn Online Practice
2025-2026 B with NGN
A nurse is reviewing the medical record of a client who is postpartum and has
preeclampsia. Which of the following laboratory results should the nurse report to the
provider?
A. Hct 39%
B. Serum albumin 4.5 g/dL
C. WBC 9,000/mm3
D. Platelets 50,000/mm3 - D. Platelets 50,000/mm3
A platelet count of 50,000/mm3 is below the expected reference range, which can
indicate disseminated intravascular coagulation. The nurse should report this result to
the provider.
A nurse is preparing to administer azithromycin to a client who is at 16 weeks of
gestation and has a positive chlamydia culture. The prescription states "Administer
azithromycin 1 g orally now." Available is 250 mg tablets. How many tablets should the
nurse administer? (Round the answer to the nearest whole number. Use a leading zero
if it applies. Do not use a trailing zero.) - 4 tablet(s)
1g = 1,000mg
1,000 mg x 1 tab = 1,000 mg/tab
1,000mg/tab / 250 mg = 4 tablet(s)
A nurse is preparing to administer oxytocin to a client who is postpartum. Which of the
following findings is an indication for the administration of the medication? (Select all
that apply.)
A. Flaccid uterus
B. Cervical laceration
C. Excess vaginal bleeding
D. Increased afterbirth cramping
E. Increased maternal temperature - A. Flaccid uterus Oxytocin increases the
contractility of the uterus.
C. Excess vaginal bleeding
Oxytocin enhances uterine contractility, decreasing vaginal bleeding.
,A mnurse mis mproviding mteaching mabout mfamily mplanning mto ma mclient mwho mhas ma mnew
mprescription mfor ma mdiaphragm. mWhich mof mthe mfollowing mstatements mshould mthe mnurse
minclude min mthe mteaching? m
m
A. "You mshould mreplace mthe mdiaphragm mevery m5 myears." m
B. "You mshould mleave mthe mdiaphragm min mplace mfor mat mleast m6 mhours mafter mintercourse."
m
C. "You mshould muse man moil-based mproduct mas ma mlubricant mwhen minserting mthe
mdiaphragm." mD. m"You mshould minsert mthe mdiaphragm mwhen myour mbladder mis mfull." m-
mB. m"You mshould mleave mthe mdiaphragm min mplace mfor mat mleast m6 mhours mafter
mintercourse." m
m
The mclient mshould mkeep mthe mdiaphragm min mplace mfor mat mleast m6 mhr mafter
mintercourse mto m
m
provide mprotection magainst
mpregnancy.
m
A mnurse mis mteaching ma mclient mwho mis mRh mnegative mabout mRho(D) mimmune mglobulin.
mWhich mof m
m
the mfollowing mstatements mby mthe mclient mindicates man munderstanding mof mthe
mteaching?
m
A. "I mwill mreceive mthis mmedication mif mmy mbaby mis mRh-negative." m
B. "I mwill mreceive mthis mmedication mwhen mI mam min mlabor." m
C. "I mwill mneed ma msecond mdose mof mthis mmedication mwhen mmy mbaby mis m6 mweeks mold."
mD. m"I mwill mneed mthis mmedication mif mI mhave man mamniocentesis." m- mD. m"I mwill mneed mthis
mmedication mif mI mhave man mamniocentesis." m
m
m
Rho(D) mimmune mglobulin mis mgiven mto mclients mwho mare mRh mnegative
mfollowing man
amniocentesis mbecause mof mthe mpotential mof mfetal mRBCs mentering mthe mmaternal
mcirculation.
m
A mnurse min ma mwomen's mhealth mclinic mis mproviding mteaching mabout mnutritional mintake mto
ma mclient mwho mis mat m8 mweeks mof mgestation. mThe mnurse mshould minstruct mthe mclient mto
mincrease mher mdaily mintake mof mwhich mof mthe mfollowing mnutrients? m
m
A. Calcium m
B. Vitamin mE m
C. Iron m
D. Vitamin mD m- mC. mIron m
m
The mrecommendation mfor miron mintake mduring mpregnancy mis mhigher mthan mthat mfor
mwomen mwho mare mnot mpregnant. mFor mwomen mwho mare mpregnant, mit mis m27 mmg/day. mFor
mwomen mwho mare mnot mpregnant, mit mis m15 mmg/day mfor mwomen myounger mthan m19 myears
mold mand m18 mmg/day mfor mwomen mbetween mthe mages mof m19 mand m50 myears mold. m
m
,A mnurse mis mcaring mfor ma mclient mwho mis min mlabor mand mwhose mfetus mis min mthe mright
mocciput mposterior mposition. mThe mclient mis mdilated mto m8 mcm mand mreports mback mpain.
mWhich mof mthe mfollowing mactions mshould mthe mnurse mtake? m
m
A. Apply msacral mcounterpressure. m
B. Perform mtranscutaneous melectrical mnerve mstimulation m(TENS). m
C. Initiate mslow-paced mbreathing. m
D. Assist mwith mbiofeedback. m- mA. mApply msacral mcounterpressure. m
m
The mnurse mshould mapply msacral mcounterpressure mto massist min mrelieving mback mlabor
mpain m
m
related mto mfetal mposterior
mposition.
m
A mnurse mis mplanning mcare mfor ma mclient mwho mis min mlabor mand mis mrequesting mepidural
manesthesia mfor mpain mcontrol. mWhich mof mthe mfollowing mactions mshould mthe mnurse
minclude min mthe mplan mof mcare? m
m
A. Place mthe mclient min ma msupine mposition mfor m30 mmin mfollowing mthe mfirst mdose mof
manesthetic msolution. m
B. Administer m1,000 mmL mof mdextrose m5% min mwater mprior mto mthe mfirst mdose mof
manesthetic msolution. m
C. Monitor mthe mclient's mblood mpressure mevery m5 mmin mfollowing mthe mfirst mdose mof
manesthetic msolution. m
D. Ensure mthe mclient mhas mbeen mNPO m4 mhr mprior mto mthe mplacement mof mthe mepidural
mand mthe mfirst mdose mof manesthetic msolution. m- mC. mMonitor mthe mclient's mblood mpressure
mevery m5 mmin mfollowing mthe mfirst mdose mof manesthetic msolution. m
m
The mnurse mshould mplan mto mobtain ma mbaseline mblood mpressure mprior mto mthe minitiation mof
manesthetic msolution. mThe mnurse mshould mthen mcontinue mto mmonitor mthe mclient's mblood
mpressure mevery m5 mto m10 mmin mto massess mfor mmaternal mhypotension mcaused mby mthe
manesthetic msolution. m
m
A mnurse mis mcaring mfor ma mclient mwho mis min mlabor mand mreports mincreasing mrectal
mpressure. mShe m
m
is mexperiencing mcontractions m2 mto m3 mmin mapart, meach mlasting m80 mto m90 mseconds,
mand ma
vaginal mexamination mreveals mthat mher mcervix mis mdilated mto m9 mcm. mThe mnurse mshould
midentify m
m
that mthe mclient mis min mwhich mof mthe mfollowing mphases mof
mlabor?
m
m
A.
mActive
m
B.
mTransition
, m
C.
mLatent
D. mDescent m- mB.
mTransition
m
The mnurse mshould midentify mthat mthe mclient mis min mthe mtransition mphase mof mlabor. mThis
mphase mis m
m
characterized mby ma mcervical mdilatation mof m8 mto m10 mcm mand mcontractions mevery m2 mto
m3 mmin,
m
each mlasting m45 mto m90
mseconds.
m
A mschool mnurse mis mproviding mteaching mto man madolescent mabout mlevonorgestrel
mcontraception. mWhich mof mthe mfollowing minformation mshould mthe mnurse minclude min mthe
mteaching? m
m
A. "You mshould mtake mthe mmedication mwithin m72 mhours mfollowing munprotected msexual
mintercourse." m
B. "You mshould mavoid mtaking mthis mmedication mif myou mare mon man moral mcontraceptive." m
C. "If myou mdon't mstart myour mperiod mwithin m5 mdays mof mtaking mthis mmedication, myou mwill
mneed ma mpregnancy mtest." m
D. "One mdose mof mthis mmedication mwill mprevent myou mfrom mbecoming mpregnant mfor m14
mdays mafter mtaking mit." m- mA. m"You mshould mtake mthe mmedication mwithin m72 mhours
mfollowing munprotected msexual mintercourse." m
m
Levonorgestrel mis man memergency mcontraceptive mwhich minhibits movulation mto mprevent
mconception. mThe mnurse mshould minstruct mthe madolescent mto mtake mthis mmedication mas
msoon mas mpossible mwithin m72 mhr mafter munprotected msexual mintercourse. m
m
A mnurse mis massessing ma mnewborn mwho mis m12 mhr mold. mWhich mof mthe mfollowing
mmanifestations m
m
requires mintervention mby mthe
mnurse?
m
A. Acrocyanosis mof mthe mextremities m
B. Murmur mat mthe mleft msternal mborder m
C. Substernal mchest mretractions mwhile msleeping m
D. Positive mBabinski mreflex m- mC. mSubsternal mchest mretractions mwhile msleeping m
m
Substernal mchest mretractions mcan mindicate mrespiratory mdistress msyndrome min mthe
mnewborn. m
m
This mmanifestation mrequires mfurther massessment mand mintervention mby mthe
mnurse.
m
A mnurse mis massessing ma mclient mwho mgave mbirth mvaginally m12 mhr mago mand mpalpates mher
muterus m
2025-2026 B with NGN
A nurse is reviewing the medical record of a client who is postpartum and has
preeclampsia. Which of the following laboratory results should the nurse report to the
provider?
A. Hct 39%
B. Serum albumin 4.5 g/dL
C. WBC 9,000/mm3
D. Platelets 50,000/mm3 - D. Platelets 50,000/mm3
A platelet count of 50,000/mm3 is below the expected reference range, which can
indicate disseminated intravascular coagulation. The nurse should report this result to
the provider.
A nurse is preparing to administer azithromycin to a client who is at 16 weeks of
gestation and has a positive chlamydia culture. The prescription states "Administer
azithromycin 1 g orally now." Available is 250 mg tablets. How many tablets should the
nurse administer? (Round the answer to the nearest whole number. Use a leading zero
if it applies. Do not use a trailing zero.) - 4 tablet(s)
1g = 1,000mg
1,000 mg x 1 tab = 1,000 mg/tab
1,000mg/tab / 250 mg = 4 tablet(s)
A nurse is preparing to administer oxytocin to a client who is postpartum. Which of the
following findings is an indication for the administration of the medication? (Select all
that apply.)
A. Flaccid uterus
B. Cervical laceration
C. Excess vaginal bleeding
D. Increased afterbirth cramping
E. Increased maternal temperature - A. Flaccid uterus Oxytocin increases the
contractility of the uterus.
C. Excess vaginal bleeding
Oxytocin enhances uterine contractility, decreasing vaginal bleeding.
,A mnurse mis mproviding mteaching mabout mfamily mplanning mto ma mclient mwho mhas ma mnew
mprescription mfor ma mdiaphragm. mWhich mof mthe mfollowing mstatements mshould mthe mnurse
minclude min mthe mteaching? m
m
A. "You mshould mreplace mthe mdiaphragm mevery m5 myears." m
B. "You mshould mleave mthe mdiaphragm min mplace mfor mat mleast m6 mhours mafter mintercourse."
m
C. "You mshould muse man moil-based mproduct mas ma mlubricant mwhen minserting mthe
mdiaphragm." mD. m"You mshould minsert mthe mdiaphragm mwhen myour mbladder mis mfull." m-
mB. m"You mshould mleave mthe mdiaphragm min mplace mfor mat mleast m6 mhours mafter
mintercourse." m
m
The mclient mshould mkeep mthe mdiaphragm min mplace mfor mat mleast m6 mhr mafter
mintercourse mto m
m
provide mprotection magainst
mpregnancy.
m
A mnurse mis mteaching ma mclient mwho mis mRh mnegative mabout mRho(D) mimmune mglobulin.
mWhich mof m
m
the mfollowing mstatements mby mthe mclient mindicates man munderstanding mof mthe
mteaching?
m
A. "I mwill mreceive mthis mmedication mif mmy mbaby mis mRh-negative." m
B. "I mwill mreceive mthis mmedication mwhen mI mam min mlabor." m
C. "I mwill mneed ma msecond mdose mof mthis mmedication mwhen mmy mbaby mis m6 mweeks mold."
mD. m"I mwill mneed mthis mmedication mif mI mhave man mamniocentesis." m- mD. m"I mwill mneed mthis
mmedication mif mI mhave man mamniocentesis." m
m
m
Rho(D) mimmune mglobulin mis mgiven mto mclients mwho mare mRh mnegative
mfollowing man
amniocentesis mbecause mof mthe mpotential mof mfetal mRBCs mentering mthe mmaternal
mcirculation.
m
A mnurse min ma mwomen's mhealth mclinic mis mproviding mteaching mabout mnutritional mintake mto
ma mclient mwho mis mat m8 mweeks mof mgestation. mThe mnurse mshould minstruct mthe mclient mto
mincrease mher mdaily mintake mof mwhich mof mthe mfollowing mnutrients? m
m
A. Calcium m
B. Vitamin mE m
C. Iron m
D. Vitamin mD m- mC. mIron m
m
The mrecommendation mfor miron mintake mduring mpregnancy mis mhigher mthan mthat mfor
mwomen mwho mare mnot mpregnant. mFor mwomen mwho mare mpregnant, mit mis m27 mmg/day. mFor
mwomen mwho mare mnot mpregnant, mit mis m15 mmg/day mfor mwomen myounger mthan m19 myears
mold mand m18 mmg/day mfor mwomen mbetween mthe mages mof m19 mand m50 myears mold. m
m
,A mnurse mis mcaring mfor ma mclient mwho mis min mlabor mand mwhose mfetus mis min mthe mright
mocciput mposterior mposition. mThe mclient mis mdilated mto m8 mcm mand mreports mback mpain.
mWhich mof mthe mfollowing mactions mshould mthe mnurse mtake? m
m
A. Apply msacral mcounterpressure. m
B. Perform mtranscutaneous melectrical mnerve mstimulation m(TENS). m
C. Initiate mslow-paced mbreathing. m
D. Assist mwith mbiofeedback. m- mA. mApply msacral mcounterpressure. m
m
The mnurse mshould mapply msacral mcounterpressure mto massist min mrelieving mback mlabor
mpain m
m
related mto mfetal mposterior
mposition.
m
A mnurse mis mplanning mcare mfor ma mclient mwho mis min mlabor mand mis mrequesting mepidural
manesthesia mfor mpain mcontrol. mWhich mof mthe mfollowing mactions mshould mthe mnurse
minclude min mthe mplan mof mcare? m
m
A. Place mthe mclient min ma msupine mposition mfor m30 mmin mfollowing mthe mfirst mdose mof
manesthetic msolution. m
B. Administer m1,000 mmL mof mdextrose m5% min mwater mprior mto mthe mfirst mdose mof
manesthetic msolution. m
C. Monitor mthe mclient's mblood mpressure mevery m5 mmin mfollowing mthe mfirst mdose mof
manesthetic msolution. m
D. Ensure mthe mclient mhas mbeen mNPO m4 mhr mprior mto mthe mplacement mof mthe mepidural
mand mthe mfirst mdose mof manesthetic msolution. m- mC. mMonitor mthe mclient's mblood mpressure
mevery m5 mmin mfollowing mthe mfirst mdose mof manesthetic msolution. m
m
The mnurse mshould mplan mto mobtain ma mbaseline mblood mpressure mprior mto mthe minitiation mof
manesthetic msolution. mThe mnurse mshould mthen mcontinue mto mmonitor mthe mclient's mblood
mpressure mevery m5 mto m10 mmin mto massess mfor mmaternal mhypotension mcaused mby mthe
manesthetic msolution. m
m
A mnurse mis mcaring mfor ma mclient mwho mis min mlabor mand mreports mincreasing mrectal
mpressure. mShe m
m
is mexperiencing mcontractions m2 mto m3 mmin mapart, meach mlasting m80 mto m90 mseconds,
mand ma
vaginal mexamination mreveals mthat mher mcervix mis mdilated mto m9 mcm. mThe mnurse mshould
midentify m
m
that mthe mclient mis min mwhich mof mthe mfollowing mphases mof
mlabor?
m
m
A.
mActive
m
B.
mTransition
, m
C.
mLatent
D. mDescent m- mB.
mTransition
m
The mnurse mshould midentify mthat mthe mclient mis min mthe mtransition mphase mof mlabor. mThis
mphase mis m
m
characterized mby ma mcervical mdilatation mof m8 mto m10 mcm mand mcontractions mevery m2 mto
m3 mmin,
m
each mlasting m45 mto m90
mseconds.
m
A mschool mnurse mis mproviding mteaching mto man madolescent mabout mlevonorgestrel
mcontraception. mWhich mof mthe mfollowing minformation mshould mthe mnurse minclude min mthe
mteaching? m
m
A. "You mshould mtake mthe mmedication mwithin m72 mhours mfollowing munprotected msexual
mintercourse." m
B. "You mshould mavoid mtaking mthis mmedication mif myou mare mon man moral mcontraceptive." m
C. "If myou mdon't mstart myour mperiod mwithin m5 mdays mof mtaking mthis mmedication, myou mwill
mneed ma mpregnancy mtest." m
D. "One mdose mof mthis mmedication mwill mprevent myou mfrom mbecoming mpregnant mfor m14
mdays mafter mtaking mit." m- mA. m"You mshould mtake mthe mmedication mwithin m72 mhours
mfollowing munprotected msexual mintercourse." m
m
Levonorgestrel mis man memergency mcontraceptive mwhich minhibits movulation mto mprevent
mconception. mThe mnurse mshould minstruct mthe madolescent mto mtake mthis mmedication mas
msoon mas mpossible mwithin m72 mhr mafter munprotected msexual mintercourse. m
m
A mnurse mis massessing ma mnewborn mwho mis m12 mhr mold. mWhich mof mthe mfollowing
mmanifestations m
m
requires mintervention mby mthe
mnurse?
m
A. Acrocyanosis mof mthe mextremities m
B. Murmur mat mthe mleft msternal mborder m
C. Substernal mchest mretractions mwhile msleeping m
D. Positive mBabinski mreflex m- mC. mSubsternal mchest mretractions mwhile msleeping m
m
Substernal mchest mretractions mcan mindicate mrespiratory mdistress msyndrome min mthe
mnewborn. m
m
This mmanifestation mrequires mfurther massessment mand mintervention mby mthe
mnurse.
m
A mnurse mis massessing ma mclient mwho mgave mbirth mvaginally m12 mhr mago mand mpalpates mher
muterus m
